Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study

NCT02895230 is registered in ClinicalTrials.gov with Rennes University Hospital as lead sponsor.

NCT NCT02895230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02895230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study
Lead sponsor
Rennes University Hospital
Phase
Observational
Overall status
Completed
Start date
January 1, 2016
Completion date
May 17, 2022
Enrollment
38,690 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgen-deprivation therapy, prostate cancer